US Stock MarketDetailed Quotes

The Oncology Institute (TOI)

Watchlist
  • 3.350
  • -0.010-0.30%
Close Jan 16 16:00 ET
  • 3.410
  • +0.060+1.79%
Post 18:47 ET
329.58MMarket Cap-5.23P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

The Oncology Institute (TOI) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1,642.12%-12.63M
34.85%-10.2M
68.60%-4.99M
26.92%-26.54M
207.53%4.19M
109.86%819K
-80.83%-15.66M
-2.79%-15.88M
41.20%-36.32M
72.19%-3.89M
Net income from continuing operations
-2.43%-16.5M
-9.88%-17.01M
1.53%-19.59M
22.16%-64.66M
29.71%-13.18M
7.50%-16.11M
8.39%-15.48M
33.70%-19.89M
-54,750.00%-83.07M
-70.38%-18.75M
Operating gains losses
1,189.84%6.22M
350.67%6.34M
27,833.33%3.35M
-389.55%-3.05M
-96.98%44K
-128.62%-571K
-311.38%-2.53M
100.35%12K
97.63%-622K
114.46%1.46M
Depreciation and amortization
9.54%1.72M
18.91%1.81M
19.81%1.78M
7.05%6.29M
8.24%1.71M
-7.36%1.57M
14.22%1.52M
17.34%1.49M
33.14%5.87M
32.30%1.58M
Deferred tax
--0
----
----
--0
--0
--0
--0
--0
71.10%-76K
71.75%-126K
Other non cash items
-49.70%1.08M
20.93%1.23M
212.64%4.87M
16.72%6.31M
2.11%1.59M
106.67%2.14M
-50.22%1.01M
102.20%1.56M
109.52%5.4M
140.63%1.56M
Change In working capital
-153.84%-6.17M
3.55%-3.29M
214.53%3.13M
665.54%18.06M
97.55%12.73M
1,131.77%11.46M
-289.12%-3.41M
42.81%-2.73M
111.48%2.36M
223.53%6.45M
-Change in receivables
-720.08%-4.04M
-272.48%-8.21M
93.93%-985K
-28.28%-5.77M
54.24%6.18M
75.90%-493K
1,040.91%4.76M
-172.46%-16.22M
77.13%-4.5M
178.12%4.01M
-Change in inventory
-354.61%-3.1M
-1,599.14%-3.48M
-206.83%-2.27M
182.99%3.64M
104.55%67K
20,366.67%1.22M
112.12%232K
313.90%2.12M
-153.18%-4.39M
-272.77%-1.47M
-Change in prepaid assets
453.00%553K
346.83%2.33M
-71.38%-1.08M
-62.40%1.18M
196.00%1.18M
-93.89%100K
-53.27%521K
-2,520.83%-629K
-26.95%3.13M
-45.73%400K
-Change in payables and accrued expense
-94.57%566K
169.24%6.13M
-34.98%7.62M
129.02%18.69M
49.07%5.4M
1,953.56%10.42M
-365.56%-8.85M
562.80%11.73M
319.62%8.16M
247.11%3.62M
-Change in other current assets
--0
18.39%-1.44M
-17.24%1.45M
-41.30%3.36M
149.52%3.39M
-100.45%-6K
-204.25%-1.77M
29.33%1.75M
9.05%5.72M
-18.65%1.36M
-Change in other current liabilities
128.98%122K
-18.08%1.39M
-8.58%-1.61M
47.44%-3.03M
-93.10%-2.83M
71.05%-421K
188.35%1.7M
-59.76%-1.48M
-16.32%-5.77M
-65.05%-1.46M
Cash from discontinued investing activities
Operating cash flow
-1,642.12%-12.63M
34.85%-10.2M
68.60%-4.99M
26.92%-26.54M
207.53%4.19M
109.86%819K
-80.83%-15.66M
-2.79%-15.88M
41.20%-36.32M
72.19%-3.89M
Investing cash flow
Cash flow from continuing investing activities
-105.81%-604K
-106.65%-1.21M
-101.04%-202K
-26.23%46.21M
-115.09%-1.76M
34.93%10.4M
-27.01%18.18M
5.36%19.39M
147.59%62.64M
135.70%11.63M
Net PPE purchase and sale
-250.25%-604K
33.84%-1.21M
46.23%-328K
17.04%-3.79M
-103.83%-1.76M
143.23%402K
-94.88%-1.83M
66.83%-610K
17.40%-4.57M
56.84%-861K
Net business purchase and sale
----
----
----
--0
--0
--0
----
----
48.05%-4.46M
66.81%-156K
Net investment purchase and sale
--0
--0
--0
-30.23%50M
--0
15.75%10M
-33.64%20M
-1.20%20M
160.99%71.66M
142.00%12.64M
Net other investing changes
--0
--0
--126K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-105.81%-604K
-106.65%-1.21M
-101.04%-202K
-26.23%46.21M
-115.09%-1.76M
34.93%10.4M
-27.01%18.18M
5.36%19.39M
147.59%62.64M
135.70%11.63M
Financing cash flow
Cash flow from continuing financing activities
4,462.14%10.6M
191.43%1.96M
-405.33%-4.74M
49.00%-3.49M
90.79%-164K
67.86%-243K
17.45%-2.15M
45.11%-938K
-107.43%-6.85M
-110.27%-1.78M
Net issuance payments of debt
27.27%-8K
-11.11%-10K
-222,233.33%-20.01M
61.39%-39K
0.00%-10K
-10.00%-11K
85.71%-9K
50.00%-9K
-100.09%-101K
47.37%-10K
Net common stock issuance
--9.95M
--0
--15.36M
--0
--0
--0
--0
--0
88.68%-1.02M
--0
Proceeds from stock option exercised by employees
--891K
110,050.00%2.2M
87.67%137K
-40.48%75K
--0
--0
--2K
--73K
-85.31%126K
-74.43%113K
Net other financing activities
-1.29%-235K
89.25%-230K
77.45%-226K
39.72%-3.53M
91.83%-154K
63.41%-232K
-30.17%-2.14M
40.75%-1M
38.99%-5.85M
-48.35%-1.88M
Cash from discontinued financing activities
Financing cash flow
4,462.14%10.6M
191.43%1.96M
-405.33%-4.74M
49.00%-3.49M
90.79%-164K
67.86%-243K
17.45%-2.15M
45.11%-938K
-107.43%-6.85M
-110.27%-1.78M
Net cash flow
Beginning cash position
-16.84%30.29M
10.22%39.74M
48.32%49.67M
139.03%33.49M
72.15%47.4M
26.07%36.42M
136.43%36.06M
139.03%33.49M
-87.84%14.01M
-55.17%27.54M
Current changes in cash
-123.99%-2.63M
-2,660.16%-9.45M
-486.83%-9.93M
-16.93%16.18M
-61.92%2.27M
908.99%10.98M
-97.30%369K
107.02%2.57M
119.25%19.48M
112.56%5.95M
End cash Position
-41.65%27.66M
-16.84%30.29M
10.22%39.74M
48.32%49.67M
48.32%49.67M
72.15%47.4M
26.07%36.42M
136.43%36.06M
139.03%33.49M
139.03%33.49M
Free cash flow
-1,183.87%-13.23M
34.75%-11.41M
67.77%-5.32M
25.82%-30.33M
151.14%2.43M
113.21%1.22M
-82.20%-17.49M
4.62%-16.49M
39.24%-40.88M
70.27%-4.75M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1,642.12%-12.63M34.85%-10.2M68.60%-4.99M26.92%-26.54M207.53%4.19M109.86%819K-80.83%-15.66M-2.79%-15.88M41.20%-36.32M72.19%-3.89M
Net income from continuing operations -2.43%-16.5M-9.88%-17.01M1.53%-19.59M22.16%-64.66M29.71%-13.18M7.50%-16.11M8.39%-15.48M33.70%-19.89M-54,750.00%-83.07M-70.38%-18.75M
Operating gains losses 1,189.84%6.22M350.67%6.34M27,833.33%3.35M-389.55%-3.05M-96.98%44K-128.62%-571K-311.38%-2.53M100.35%12K97.63%-622K114.46%1.46M
Depreciation and amortization 9.54%1.72M18.91%1.81M19.81%1.78M7.05%6.29M8.24%1.71M-7.36%1.57M14.22%1.52M17.34%1.49M33.14%5.87M32.30%1.58M
Deferred tax --0----------0--0--0--0--071.10%-76K71.75%-126K
Other non cash items -49.70%1.08M20.93%1.23M212.64%4.87M16.72%6.31M2.11%1.59M106.67%2.14M-50.22%1.01M102.20%1.56M109.52%5.4M140.63%1.56M
Change In working capital -153.84%-6.17M3.55%-3.29M214.53%3.13M665.54%18.06M97.55%12.73M1,131.77%11.46M-289.12%-3.41M42.81%-2.73M111.48%2.36M223.53%6.45M
-Change in receivables -720.08%-4.04M-272.48%-8.21M93.93%-985K-28.28%-5.77M54.24%6.18M75.90%-493K1,040.91%4.76M-172.46%-16.22M77.13%-4.5M178.12%4.01M
-Change in inventory -354.61%-3.1M-1,599.14%-3.48M-206.83%-2.27M182.99%3.64M104.55%67K20,366.67%1.22M112.12%232K313.90%2.12M-153.18%-4.39M-272.77%-1.47M
-Change in prepaid assets 453.00%553K346.83%2.33M-71.38%-1.08M-62.40%1.18M196.00%1.18M-93.89%100K-53.27%521K-2,520.83%-629K-26.95%3.13M-45.73%400K
-Change in payables and accrued expense -94.57%566K169.24%6.13M-34.98%7.62M129.02%18.69M49.07%5.4M1,953.56%10.42M-365.56%-8.85M562.80%11.73M319.62%8.16M247.11%3.62M
-Change in other current assets --018.39%-1.44M-17.24%1.45M-41.30%3.36M149.52%3.39M-100.45%-6K-204.25%-1.77M29.33%1.75M9.05%5.72M-18.65%1.36M
-Change in other current liabilities 128.98%122K-18.08%1.39M-8.58%-1.61M47.44%-3.03M-93.10%-2.83M71.05%-421K188.35%1.7M-59.76%-1.48M-16.32%-5.77M-65.05%-1.46M
Cash from discontinued investing activities
Operating cash flow -1,642.12%-12.63M34.85%-10.2M68.60%-4.99M26.92%-26.54M207.53%4.19M109.86%819K-80.83%-15.66M-2.79%-15.88M41.20%-36.32M72.19%-3.89M
Investing cash flow
Cash flow from continuing investing activities -105.81%-604K-106.65%-1.21M-101.04%-202K-26.23%46.21M-115.09%-1.76M34.93%10.4M-27.01%18.18M5.36%19.39M147.59%62.64M135.70%11.63M
Net PPE purchase and sale -250.25%-604K33.84%-1.21M46.23%-328K17.04%-3.79M-103.83%-1.76M143.23%402K-94.88%-1.83M66.83%-610K17.40%-4.57M56.84%-861K
Net business purchase and sale --------------0--0--0--------48.05%-4.46M66.81%-156K
Net investment purchase and sale --0--0--0-30.23%50M--015.75%10M-33.64%20M-1.20%20M160.99%71.66M142.00%12.64M
Net other investing changes --0--0--126K----------------------------
Cash from discontinued investing activities
Investing cash flow -105.81%-604K-106.65%-1.21M-101.04%-202K-26.23%46.21M-115.09%-1.76M34.93%10.4M-27.01%18.18M5.36%19.39M147.59%62.64M135.70%11.63M
Financing cash flow
Cash flow from continuing financing activities 4,462.14%10.6M191.43%1.96M-405.33%-4.74M49.00%-3.49M90.79%-164K67.86%-243K17.45%-2.15M45.11%-938K-107.43%-6.85M-110.27%-1.78M
Net issuance payments of debt 27.27%-8K-11.11%-10K-222,233.33%-20.01M61.39%-39K0.00%-10K-10.00%-11K85.71%-9K50.00%-9K-100.09%-101K47.37%-10K
Net common stock issuance --9.95M--0--15.36M--0--0--0--0--088.68%-1.02M--0
Proceeds from stock option exercised by employees --891K110,050.00%2.2M87.67%137K-40.48%75K--0--0--2K--73K-85.31%126K-74.43%113K
Net other financing activities -1.29%-235K89.25%-230K77.45%-226K39.72%-3.53M91.83%-154K63.41%-232K-30.17%-2.14M40.75%-1M38.99%-5.85M-48.35%-1.88M
Cash from discontinued financing activities
Financing cash flow 4,462.14%10.6M191.43%1.96M-405.33%-4.74M49.00%-3.49M90.79%-164K67.86%-243K17.45%-2.15M45.11%-938K-107.43%-6.85M-110.27%-1.78M
Net cash flow
Beginning cash position -16.84%30.29M10.22%39.74M48.32%49.67M139.03%33.49M72.15%47.4M26.07%36.42M136.43%36.06M139.03%33.49M-87.84%14.01M-55.17%27.54M
Current changes in cash -123.99%-2.63M-2,660.16%-9.45M-486.83%-9.93M-16.93%16.18M-61.92%2.27M908.99%10.98M-97.30%369K107.02%2.57M119.25%19.48M112.56%5.95M
End cash Position -41.65%27.66M-16.84%30.29M10.22%39.74M48.32%49.67M48.32%49.67M72.15%47.4M26.07%36.42M136.43%36.06M139.03%33.49M139.03%33.49M
Free cash flow -1,183.87%-13.23M34.75%-11.41M67.77%-5.32M25.82%-30.33M151.14%2.43M113.21%1.22M-82.20%-17.49M4.62%-16.49M39.24%-40.88M70.27%-4.75M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -